Inventor · disambiguated record
Alan S. Verkman
Also filed as: VERKMAN ALAN · VERKMAN ALAN S
38 granted patents·24 pending applications·164 citations·filing 1999–2025
96Inventor score
Top patents by PatentIndex Score
62 records- 0195US11230535B2CFTR regulators and methods of use thereofUNIV CALIFORNIA·Filed 2020·Granted Jan 25, 2022·5 cites·12 claims
- 0294US7414037B2Hydrazide-containing CFTR inhibitor compounds and uses thereofUNIV CALIFORNIA·Filed 2005·Granted Aug 19, 2008·38 cites·63 claims
- 0392US10604492B2CFTR regulators and methods of use thereofUNIV CALIFORNIA·Filed 2016·Granted Mar 31, 2020·5 cites·16 claims
- 0491US7939558B2Compounds having activity in increasing ion transport by mutant-CFTR and uses thereofUNIV CALIFORNIA·Filed 2005·Granted May 10, 2011·17 cites·14 claims
- 0591US7235573B2Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitorsUNIV CALIFORNIA·Filed 2003·Granted Jun 26, 2007·40 cites·3 claims
- 0690US7888332B2Hydrazide-containing CFTR inhibitor compounds and uses thereofUNIV CALIFORNIA·Filed 2008·Granted Feb 15, 2011·10 cites·39 claims
- 0790US7638543B2Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereofUNIV CALIFORNIA·Filed 2007·Granted Dec 29, 2009·9 cites·13 claims
- 0886US12391654B2CFTR regulators and methods of use thereofUNIV CALIFORNIA·Filed 2024·Granted Aug 19, 2025·0 cites·18 claims
- 0983US12065412B2CFTR regulators and methods of use thereofUNIV CALIFORNIA·Filed 2023·Granted Aug 20, 2024·0 cites·17 claims
- 1079US8394788B2Phenylsulfoxyoxazole compound inhibitors of urea transportersVERKMAN ALAN S·Filed 2007·Granted Mar 12, 2013·4 cites·40 claims
- 1179US2025367207A1Ocular pharmaceutical compositionsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 1278US9062073B2Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses thereforVERKMAN ALAN S·Filed 2012·Granted Jun 23, 2015·2 cites·34 claims
- 1378US2024156828A1Ocular pharmaceutical compositionsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1475US8143295B2Compounds having activity in correcting mutant-CFTR processing and uses thereofVERKMAN ALAN·Filed 2006·Granted Mar 27, 2012·4 cites·12 claims
- 1575US2022081402A1Cftr regulators and methods of use thereofUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1674US12187694B2SLC26A3 inhibitors and use thereofUNIV CALIFORNIA·Filed 2023·Granted Jan 7, 2025·0 cites·12 claims
- 1774US8609661B2Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses thereforVERKMAN ALAN S·Filed 2010·Granted Dec 17, 2013·3 cites·15 claims
- 1873US8389736B2Compounds having activity in correcting mutant-CFTR processing and uses thereofKURTH MARK J·Filed 2008·Granted Mar 5, 2013·4 cites·14 claims
- 1972US7696244B2Compounds having activity in increasing ion transport by mutant-CFTR and uses thereofUNIV CALIFORNIA·Filed 2004·Granted Apr 13, 2010·4 cites·28 claims
- 2071US9316633B2Methods for identifying inhibitors of solute transportersVERKMAN ALAN S·Filed 2007·Granted Apr 19, 2016·3 cites·3 claims
- 2170US11839616B2Ocular pharmaceutical compositionsUNIV CALIFORNIA·Filed 2018·Granted Dec 12, 2023·0 cites·10 claims
- 2270US8058295B2Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereofVERKMAN ALAN·Filed 2009·Granted Nov 15, 2011·1 cites·26 claims
- 2365US11591304B2SLC26A3 inhibitors and use thereofUNIV CALIFORNIA·Filed 2019·Granted Feb 28, 2023·0 cites·13 claims
- 2462US12503447B2CFTR regulators and methods of use thereofUNIV CALIFORNIA·Filed 2021·Granted Dec 23, 2025·0 cites·26 claims
- 2561US11123340B2Small-molecule UT-A-selective urea transport inhibitorsUNIV CALIFORNIA·Filed 2019·Granted Sep 21, 2021·0 cites·7 claims
- 2660US10654916B2Compositions and methods for the treatment of neuromyelitis opticaBENNETT JEFFREY L·Filed 2012·Granted May 19, 2020·1 cites·24 claims
- 2758US11390667B2Compositions and methods for the treatment of neuromyelitis opticaUNIV COLORADO REGENTS·Filed 2020·Granted Jul 19, 2022·0 cites·19 claims
- 2858US2020392226A1Enzymatic modification of anti-aqp4 autoantibody for modulating neuromyelitis opticaUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2957USRE48842EPyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses thereforUNIV CALIFORNIA·Filed 2012·Granted Dec 7, 2021·0 cites·52 claims
- 3057US2025073242A1Slc26a3 inhibitors and use thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3155US11084795B2CFTR regulators and methods of use thereofUNIV CALIFORNIA·Filed 2016·Granted Aug 10, 2021·0 cites·18 claims
- 3254US11192869B2CFTR regulators and methods of use thereofUNIV CALIFORNIA·Filed 2019·Granted Dec 7, 2021·0 cites·28 claims
- 3354US8129365B2Water-soluble, fluorescent compounds for detection of potassium ionsVERKMAN ALAN·Filed 2006·Granted Mar 6, 2012·1 cites·54 claims
- 3454US2011015239A1Inhibitors of calcium-activated chloride channelsUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 3552US9789095B2Inhibitors of calcium-activated chloride channelsUNIV CALIFORNIA·Filed 2015·Granted Oct 17, 2017·0 cites·17 claims
- 3652US2013143765A1Inhibitors of calcium-activated chloride channelsVERKMAN ALAN S·Filed 2012·Application pending·0 cites
- 3752US2011119775A1Hydrazide-containing cftr inhibitor compounds and uses thereofUNIV CALIFORNIA·Filed 2011·Application pending·0 cites
- 3851US2009253799A1Divalent hydrazide compound conjugates for inhibiting cystic fibrosis transmembrane conductance regulatorUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 3951US2022071549A1Apparatus, systems and methods of use for ocular surface potential difference measurementUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 4051US2011105565A1Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulatorUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 4151US2022280514A1Methods of treating bile acid diarrheaUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 4250US12390473B2Methods of treating tyrosine kinase inhibitor-induced diarrheaUNIV CALIFORNIA·Filed 2020·Granted Aug 19, 2025·0 cites·10 claims
- 4350US2019352394A1Enzymatic modification of anti-aqp4 autoantibody for modulating neuromyelitis opticaUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 4449US12038430B2Methods for high-content drug screeningUNIV CALIFORNIA·Filed 2019·Granted Jul 16, 2024·0 cites·50 claims
- 4548US8552067B2Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereforVERKMAN ALAN S·Filed 2007·Granted Oct 8, 2013·0 cites·37 claims
- 4648US2015139981A1Enzymatic modification of anti-aqp4 autoantibody for modulating neuromyelitis opticaUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 4748US2016053023A1Methods of treatment for neuromyelitis opticaANNEXON INC·Filed 2014·Application pending·0 cites
- 4847US9790218B2Small molecule activators of calcium-activated chloride channels and methods of useVERKMAN ALAN S·Filed 2012·Granted Oct 17, 2017·0 cites·8 claims
- 4947US2011053995A1Benzenesulfonanilide compound inhibitors of urea transportersUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 5047US2004063695A1Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereofFiled 2002·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alan S. Verkman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →